Skin Cancer

A phase 3 randomized trial of nicotinamide for skin cancer chemoprevention  NEJM2015;373 :1618-1626  October 22 2015



Cancer Risk

Serum hydroxyvitamin D Concentrations > 40 ng/ml are associated with >65% lower cancer risk. Pooled Analysis of Randomized Trial and Prospective Cohort Study  PLOS ONE April 6,2016

Solar Radiation and the Incidence and mortality of leading invasive cancers in the United States    DermatoEndocrinology 2016 Jan-Dec8(1)

The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitaminD on cancer outcome:systemic review and meta-analysis British Journal of Cancer (2017) 116-1092-1110



Colon cancer

Circulating 25-hydroxyvitamin D levels and Survival in Patients with Colon Cancer.  Journal of Clinical Oncology Vol 26 No 18

Association Between Vitamin D and the Risk of Colorectal Cancer:A Systemic Review of Prospective Studies  Journal of Clinical Oncology Vol 29 No 28

Could Vitamin D Sufficiency improve the survival of colorectal cancer patients? J Steroid Biochem Mol Biol 2014 Dec 19

Racial Disparity in death from colorectal cancer : does vitamin D deficiency contribute?Cancer 2011 March 1”117(5)1061-9




Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes    Oncotarget June 28 2017





The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review    Iran J Cancer Prevention 2016 June 9(3):e4469

Pretreatment Serum concentrations of 25-hydroxyvitamin D and Breast Cancer Prognosis Characteristics: A Case Control and Case Series Study   Plos one 2011 Feb 28:6(2)

Relationship between low unltrviolet B irradiance and higher breast cancer risk in 107 countries Breast J 2008 May-Jun;14(3)255-260




A prospective study of plasma vitamin D metabolites,vitamin D receptor polymorphisms and prostate cancer PLOS MED March 20  2007

Side effects:25-Hydroxyvitamin D in the range of 20-100 ng/ml and the incidence of kidney stones Am J Public Health 2014 Sept 10 (9) 1783-7

Prostate cancer survival is dependent on season of diagnosis   Prostate 2007 Sept !;67 (12) 1362-70